KATHLEEN MORRIS: Open Payments
NPI 1871141325 · SELBYVILLE, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$771 in 35 payments from 13 companies in 2025. Trend: 2023 $816 · 2024 $1,100 · 2025 $771
Food & beverage: $771
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 8 | $258 |
| Lilly USA, LLC | 5 | $103 |
| Novo Nordisk Inc | 5 | $101 |
| SANOFI-AVENTIS U.S. LLC | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Exact Sciences Corporation | 2 | $39 |
| Amgen Inc. | 2 | $38 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| PFIZER INC. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: Korlym, MOUNJARO, TZIELD, Wegovy, GARDASIL 9, The Cologuard Plus Collection Kit, EVENITY, PREVNAR 20.
Industry payments across DE — which companies pay providers there.
